|
ZNF304 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.32279973033656E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.2235994963421E-10 |
| Normal-vs-Stage2 |
2.20579999998805E-06 |
| Normal-vs-Stage3 |
3.2616000000818E-07 |
| Normal-vs-Stage4 |
9.41300000167899E-08 |
| Stage1-vs-Stage2 |
8.253800E-01 |
| Stage1-vs-Stage3 |
1.671160E-01 |
| Stage1-vs-Stage4 |
1.095180E-01 |
| Stage2-vs-Stage3 |
3.860400E-01 |
| Stage2-vs-Stage4 |
1.466040E-01 |
| Stage3-vs-Stage4 |
5.284200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.73300329221161E-11 |
| Normal-vs-AfricanAmerican |
1.3845999999873E-06 |
| Normal-vs-Asian |
3.970200E-04 |
| Caucasian-vs-AfricanAmerican |
3.512200E-01 |
| Caucasian-vs-Asian |
9.133800E-01 |
| AfricanAmerican-vs-Asian |
6.729000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.31290534000073E-11 |
| Normal-vs-Female |
1.014720E-04 |
| Male-vs-Female |
2.682800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.99956999999973E-05 |
| Normal-vs-Extreme_Weight |
4.78350692389995E-12 |
| Normal-vs-Obese |
1.67819999996599E-06 |
| Normal-vs-Extreme_Obese |
1.90614999999728E-05 |
| Normal_Weight-vs-Extreme_Weight |
9.328500E-02 |
| Normal_Weight-vs-Obese |
8.041600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.126400E-01 |
| Extreme_Weight-vs-Obese |
2.819800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.658600E-01 |
| Obese-vs-Extreme_Obese |
3.041000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.983700E-04 |
| Normal-vs-Age(41-60Yrs) |
2.14130000397716E-08 |
| Normal-vs-Age(61-80Yrs) |
5.50960388423505E-11 |
| Normal-vs-Age(81-100Yrs) |
4.12159999463313E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.826800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.754200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.448200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.379040E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.100610E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.726600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.17789999976026E-09 |
| Normal-VS-Type2 PRCC |
3.81084053202585E-12 |
| Normal-VS-KIRP CIMP |
2.574100E-02 |
| Normal-VS-Unclassified PRCC |
6.574000E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.850000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.849600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.846170E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.339800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.792260E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.752000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.43201031430362E-13 |
| Normal-vs-N1 |
2.356600E-04 |
| Normal-vs-N2 |
8.25979999999893E-05 |
| N0-vs-N1 |
4.142400E-01 |
| N0-vs-N2 |
4.675000E-01 |
| N1-vs-N2 |
4.384600E-01 |
|
|
